Long-term follow-up of diabetic macular edema treated with dexamethasone implant: a real-life study

2020 ◽  
Vol 57 (12) ◽  
pp. 1413-1421 ◽  
Author(s):  
Thibaud Mathis ◽  
Théo Lereuil ◽  
Amro Abukashabah ◽  
Nicolas Voirin ◽  
Aditya Sudhalkar ◽  
...  
Keyword(s):  
Macular Edema ◽  
Diabetic Macular Edema ◽  
Real Life ◽  
Dexamethasone Implant ◽  
Life Study ◽  
Long Term Follow Up ◽  
Real Life Study

REAL-LIFE STUDY IN DIABETIC MACULAR EDEMA TREATED WITH DEXAMETHASONE IMPLANT

Retina ◽  
2017 ◽  
Vol 37 (4) ◽  
pp. 753-760 ◽  
Author(s):  
Ariane Malclès ◽  
Corinne Dot ◽  
Nicolas Voirin ◽  
Émilie Agard ◽  
Anne-Laure Vié ◽  
...  
Keyword(s):  
Macular Edema ◽  
Diabetic Macular Edema ◽  
Real Life ◽  
Dexamethasone Implant ◽  
Life Study ◽  
Real Life Study

Predictors of Nabiximols (Sativex®) discontinuation over long-term follow-up: a real-life study

2020 ◽  
Vol 267 (6) ◽  
pp. 1737-1743 ◽  
Author(s):  
Antonio Carotenuto ◽  
Teresa Costabile ◽  
Mario De Lucia ◽  
Marcello Moccia ◽  
Fabrizia Falco ◽  
...  
Keyword(s):  
Real Life ◽  
Life Study ◽  
Long Term Follow Up ◽  
Real Life Study

LONG-TERM FOLLOW-UP OF VITRECTOMY FOR DIFFUSE NONTRACTIONAL DIABETIC MACULAR EDEMA

Retina ◽  
2009 ◽  
Vol 29 (4) ◽  
pp. 464-472 ◽  
Author(s):  
KAZUYUKI KUMAGAI ◽  
MARIKO FURUKAWA ◽  
NOBUCHIKA OGINO ◽  
ERIC LARSON ◽  
MASAYOSHI IWAKI ◽  
...  
Keyword(s):  
Macular Edema ◽  
Diabetic Macular Edema ◽  
Long Term Follow Up

Efficacy and safety of ranibizumab in diabetic macular edema: real life study

2015 ◽  
Vol 93 ◽  
pp. n/a-n/a
Author(s):  
L. Hrarat ◽  
F. Fajnkuchen ◽  
V. Sarda ◽  
T. Grenet ◽  
S. Buffet ◽  
...  
Keyword(s):  
Macular Edema ◽  
Diabetic Macular Edema ◽  
Real Life ◽  
Efficacy And Safety ◽  
Life Study ◽  
Real Life Study

scholarly journals The Effects of Epiretinal Membranes on the Treatment Outcomes of Dexamethasone Implants in Diabetic Macular Edema: A Real-Life Study

2020 ◽  
Vol 36 (5) ◽  
pp. 298-303
Author(s):  
Burak Erden ◽  
Akın Çakır ◽  
Selim Bölükbaşı ◽  
Şeyma Gülcenur Özturan ◽  
Mustafa Nuri Elçioğlu
Keyword(s):  
Macular Edema ◽  
Treatment Outcomes ◽  
Diabetic Macular Edema ◽  
Real Life ◽  
Epiretinal Membranes ◽  
Life Study ◽  
Real Life Study

scholarly journals Three Year Outcomes of Intravitreal Ranibizumab and Aflibercept Treatment of Patients with Diabetic Macular Edema in a Real-World Setting

2021 ◽  
Author(s):  
Yusuf Berk Akbaş ◽  
Cengiz Alagöz ◽  
Semih Çakmak ◽  
Gökhan Demir ◽  
Neşe Alagöz ◽  
...  
Keyword(s):  
Macular Edema ◽  
Diabetic Macular Edema ◽  
Real Life ◽  
Intravitreal Ranibizumab ◽  
Life Study ◽  
Corrected Visual Acuity ◽  
Real World Setting ◽  
Change In Mean ◽  
Anatomical Outcomes

Abstract PurposeTo evaluate and compare the functional and anatomical outcomes of intravitreal ranibizumab (IVR) and aflibercept (IVA) treatments in patients with diabetic macular edema (DME).MethodsFour hundred three eyes of 235 naïve patients who underwent IVR or IVA treatment for diabetic macular edema and followed up to 36 months included in this retrospective, real-life study. All patients underwent 3 loading doses and followed up with a PRN regimen. Best corrected visual acuity (BCVA) and central macular thickness (CMT) were measured at baseline, year 1, 2 and 3. ResultsThere were 198 eyes in IVR group and 205 eyes in IVA group. The changes in mean BCVA were 0.09±0.32 vs 0.17±0.41 logMAR (p=0.042) at year 1, 0.09±0.37 vs 0.12±0.45 logMAR (p=0.512) at year 2 and 0.13± 0.36 vs 0.15±0.48 logMAR (p=0.824) at year 3 in IVA and IVR groups, respectively. The baseline mean BCVA were lower (p=0.004) in IVA group. In terms of CMT changes, there were no differences between groups. ConclusionAt year 1, change in mean BCVA was statistically significantly higher in IVA group, however this difference did not persist at year 2 and 3. Both ranibizumab and aflibercept treatments achieved a good long-term visual and anatomical response in DME patients.

Sign in / Sign up

Export Citation Format

Share Document